Economic Cost of U.S. Suicide and Nonfatal Self-harm

Cora Peterson,Tadesse Haileyesus,Deborah M. Stone
DOI: https://doi.org/10.1016/j.amepre.2024.03.002
IF: 6.604
2024-03-31
American Journal of Preventive Medicine
Abstract:Introduction The U.S. age-adjusted suicide rate is 35% higher than two decades ago and the COVID-19 pandemic era highlighted the urgent need to address nonfatal self-harm, particularly among youth. This study aimed to report the estimated annual economic cost of U.S. suicide and nonfatal self-harm. Methods In 2023 CDC's WISQARS Cost of Injury provided the retrospective number of suicides and nonfatal self-harm injury emergency department (ED) visits from national surveillance sources by sex and age group, as well as the estimated annual economic cost of associated medical spending, lost work productivity, reduced quality of life from injury morbidity, and avoidable mortality based on the value of statistical life during 2015–2020. Results The economic cost of suicide and nonfatal self-harm averaged 356B of 19B of $26B). Conclusions Suicide and self-harm have substantial societal costs. Measuring the consequences in terms of comprehensive economic cost can inform investments in suicide prevention strategies.
medicine, general & internal,public, environmental & occupational health
What problem does this paper attempt to address?